U.s. Government is a topic tracked in our intelligence system with 5 linked articles.
Colossal Biosciences is reportedly seeking new capital at a $20–$30 billion valuation, backed by prior $60 million government investments and multiple spinouts with notable funding/valuations, signaling potential upside but substantial execution and regulatory risks.
DeepMind CEO Demis Hassabis proposes an independent, FINRA-like standards body to regulate frontier AI, including a 30-day pre-release review for Frontier Labs and potential US deployment only after passing the assessment, backed by government support and industry funding to balance safety and innovation.
US claims ASML’s top chip tool may be in China while ASML denies it, highlighting export-license regulatory risk for ASML.
Defense startups are flush with funding as valuations surge and the U.S. contemplates a sizable defense-budget bump, but many will struggle to convert prototypes into durable revenue due to procurement hurdles.
Defense-tech funding is surging as the U.S. considers a 40% defense-budget rise, with Anduril and Mach Industries seeing large valuation jumps; investor Ross Fubini warns many new startups will struggle to convert prototypes into contracts.
Intel’s turnaround narrative has driven ~490% stock growth on Wall Street optimism around CEO Lip-Bu Tan, aided by a government stake and early manufacturing talks with Apple and Tesla, even as core fundamentals lag.
Subscribe for real-time topic updates and unlimited access to our intelligence platform.